publicationMetadata:
  pmid: "24414536"
  title: "mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma."
  queryType: "bench"  # From PubMed query (hint only)
  publicationType: "Lab Research"
  publicationTypeConfidence: 0.95
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Based on publication type (Lab Research), expected tool categories include:
    - Animal models (genetically modified mouse model, allografted mice)
    - Cell lines (Nf2(-/-) Schwann cells, in vitro cell models)
    - Genetic reagents (Nf2 knockout constructs)
    - Computational tools (potentially for data analysis)
    
    This is a laboratory research study involving both in vitro cell culture experiments
    and in vivo mouse models to test therapeutic interventions. The methods clearly
    indicate experimental usage of multiple research tools.
  overallAssessment: |
    This is a laboratory research publication that clearly uses multiple research tools
    for experimental purposes. The study involves in vitro cell models, genetically
    modified mouse models, and therapeutic compounds (rapamycin, sirolimus). The presence
    of a Methods section and experimental design strongly indicates tool usage.

toolValidations: []  # No tools were mined, so no validations to perform

potentiallyMissedTools:
  - toolName: "Nf2(-/-) Schwann cells"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "We studied in vitro cell models, cohorts of mice allografted with Nf2(-/-) Schwann cells, and a genetically modified mouse model"
    whyMissed: "Cell line with genetic modification notation should have been detected by cell line patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "genetically modified mouse model of NF2 schwannoma"
    toolType: "animal_model"
    foundIn: "methods"
    contextSnippet: "cohorts of mice allografted with Nf2(-/-) Schwann cells, and a genetically modified mouse model of NF2 schwannoma in order to evaluate"
    whyMissed: "Explicit mention of genetically modified mouse model should have been caught by animal model patterns"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "rapamycin"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "We found that treatment with the mTORC1 inhibitor rapamycin reduced the severity of NF2-related Schwann cell tumorigenesis"
    whyMissed: "Therapeutic compound used in experimental treatment should be detected as genetic reagent/small molecule"
    confidence: 0.85
    shouldBeAdded: Yes

  - toolName: "sirolimus"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "in an NF2 patient with growing vestibular schwannomas, the rapalog sirolimus induced tumor growth arrest"
    whyMissed: "Therapeutic compound (rapalog) used in treatment should be detected as genetic reagent/small molecule"
    confidence: 0.85
    shouldBeAdded: Yes

  - toolName: "in vitro cell models"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "We studied in vitro cell models, cohorts of mice allografted with Nf2(-/-) Schwann cells"
    whyMissed: "General reference to cell models, though less specific than the Nf2(-/-) Schwann cells"
    confidence: 0.7
    shouldBeAdded: Maybe

suggestedPatterns:
  - patternType: "naming_convention"
    pattern: "Nf2\\(-/-\\)|Nf2\\+/-|[A-Za-z0-9]+\\(-/-\\)|[A-Za-z0-9]+\\+/-"
    toolType: "cell_line"
    examples: ["Nf2(-/-) Schwann cells"]
    reasoning: "Genetic knockout/heterozygous notation is a strong indicator of genetically modified cell lines or animal models"

  - patternType: "context_phrase"
    pattern: "genetically modified mouse model|transgenic mouse|knockout mouse|mouse model of"
    toolType: "animal_model"
    examples: ["genetically modified mouse model of NF2 schwannoma"]
    reasoning: "These phrases explicitly indicate engineered animal models used for research"

  - patternType: "context_phrase"
    pattern: "treatment with|treated with|inhibitor [a-zA-Z]+|compound [a-zA-Z]+"
    toolType: "genetic_reagent"
    examples: ["treatment with the mTORC1 inhibitor rapamycin"]
    reasoning: "Treatment context with specific compounds indicates experimental use of chemical reagents"

  - patternType: "term"
    pattern: "rapamycin|sirolimus|rapalog"
    toolType: "genetic_reagent"
    examples: ["rapamycin", "sirolimus", "rapalog sirolimus"]
    reasoning: "Specific therapeutic compounds used in experimental treatments should be captured"

  - patternType: "context_phrase"
    pattern: "allografted with|transplanted with|injected with"
    toolType: "cell_line"
    examples: ["mice allografted with Nf2(-/-) Schwann cells"]
    reasoning: "Transplantation context indicates experimental use of cell lines in animal models"

observations:
  - resourceName: "Nf2(-/-) Schwann cells"
    resourceType: "Cell Line"
    observationType: "Tumor Growth"
    observationTypeOntologyId: "MP:0002006"
    details: |
      Nf2(-/-) Schwann cells were used in allografted mouse models and showed reduced
      tumorigenesis severity when treated with rapamycin. The cells demonstrated
      tumorigenic potential when transplanted into mice, and this tumorigenesis
      was reduced by mTORC1 inhibition without significant toxicity.
    foundIn: "results"
    contextSnippet: "treatment with the mTORC1 inhibitor rapamycin reduced the severity of NF2-related Schwann cell tumorigenesis without significant toxicity"
    confidence: 0.9
    doi: "10.1093/neuonc/not242"

  - resourceName: "genetically modified mouse model of NF2 schwannoma"
    resourceType: "Animal Model"
    observationType: "Tumor Growth"
    observationTypeOntologyId: "MP:0002006"
    details: |
      The genetically modified mouse model of NF2 schwannoma was used to evaluate
      targeted therapy efficacy. The model demonstrated tumor growth that could
      be modulated by mTORC1 pathway inhibition, providing evidence for therapeutic
      intervention effectiveness.
    foundIn: "results"
    contextSnippet: "treatment with the mTORC1 inhibitor rapamycin reduced the severity of NF2-related Schwann cell tumorigenesis"
    confidence: 0.85
    doi: "10.1093/neuonc/not242"

  - resourceName: "rapamycin"
    resourceType: "Genetic Reagent"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      Rapamycin was used as an mTORC1 inhibitor and demonstrated efficacy in reducing
      NF2-related Schwann cell tumorigenesis severity without significant toxicity.
      The compound showed therapeutic potential for NF2 treatment in both cell culture
      and animal model systems.
    foundIn: "results"
    contextSnippet: "treatment with the mTORC1 inhibitor rapamycin reduced the severity of NF2-related Schwann cell tumorigenesis without significant toxicity"
    confidence: 0.9
    doi: "10.1093/neuonc/not242"

  - resourceName: "sirolimus"
    resourceType: "Genetic Reagent"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      Sirolimus (a rapalog) was used in an NF2 patient with growing vestibular
      schwannomas and induced tumor growth arrest. This clinical observation
      supports the therapeutic potential of mTORC1 inhibitors for NF2 treatment.
    foundIn: "results"
    contextSnippet: "in an NF2 patient with growing vestibular schwannomas, the rapalog sirolimus induced tumor growth arrest"
    confidence: 0.85
    doi: "10.1093/neuonc/not242"

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 5
  newPatternsCount: 5
  observationsExtracted: 4
  observationsByType:
    Tumor Growth: 2
    Usage Instructions: 2
  majorIssuesFound: |
    - No tools were mined from this publication despite clear evidence of multiple research tools
    - Mining system completely failed to detect obvious tools including:
      * Nf2(-/-) Schwann cells (genetically modified cell line)
      * Genetically modified mouse model of NF2 schwannoma
      * Therapeutic compounds (rapamycin, sirolimus)
    - This represents a significant mining failure for a laboratory research publication
    - The publication clearly describes experimental usage of multiple tool types
  recommendations: |
    This publication should have yielded multiple validated research tools but the mining
    system detected none. This indicates serious gaps in the mining patterns:
    
    1. All 5 potentially missed tools should be added to the database
    2. The suggested patterns should be implemented to catch similar tools in future mining
    3. Special attention needed for genetic knockout notation (Nf2(-/-)) and therapeutic compounds
    4. This case demonstrates the need for better detection of:
       - Genetically modified cell lines with knockout notation
       - Animal models described with "genetically modified" terminology
       - Therapeutic compounds used in experimental treatments
    5. The observations extracted show clear experimental findings that validate tool usage
    6. This publication type (laboratory research with Methods section) should reliably yield tools
